Lipid remodeling in mouse liver and plasma resulting from Δ6 fatty acid desaturase inhibition

Kevin L. Duffin, Mark G. Obukowicz*, William J. Salsgiver, Dean J. Welsch, Caroline Shieh, Amiram Raz, Philip Needleman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Electrospray/tandem mass spectrometry was used to quantify lipid remodeling in mouse liver and plasma during inhibition of polyunsaturated fatty acid synthesis by the Δ26 fatty acid desaturase inhibitor, SC-26196. SC-26196 caused increases in linoleic acid and corresponding decreases in arachidonic acid and docosahexaenoic acid in select molecular species of phosphatidylcholine, phosphatidylethanolamine, and cholesterol esters but not in phosphatidylserine, phosphatidylinositol, or triglycerides. For linoleic acid-, arachidonic acid-, and docosahexaenoic acid-containing phospholipid species, this difference was, in part, determined by the fatty acid at the sn-1 position, namely, palmitic or stearic acid. An understanding of phospholipid remodeling mediated by Δ6 desaturase inhibition should aid in clarifying the contribution of arachidonic acid derived via de novo synthesis or obtained directly in the diet during inflammatory responses.

Original languageEnglish
Pages (from-to)1203-1208
Number of pages6
Issue number11
StatePublished - 2001


Dive into the research topics of 'Lipid remodeling in mouse liver and plasma resulting from Δ6 fatty acid desaturase inhibition'. Together they form a unique fingerprint.

Cite this